160 related articles for article (PubMed ID: 9709269)
1. Screening fundamentals.
Smith RA
J Natl Cancer Inst Monogr; 1997; (22):15-9. PubMed ID: 9709269
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
3. After 40 years, mammography remains as much emotion as science.
Randal J
J Natl Cancer Inst; 2000 Oct; 92(20):1630-2. PubMed ID: 11036103
[No Abstract] [Full Text] [Related]
4. Breast cancer screening among women younger than age 50: a current assessment of the issues.
Smith RA
CA Cancer J Clin; 2000; 50(5):312-36. PubMed ID: 11075240
[TBL] [Abstract][Full Text] [Related]
5. [Cost-effectiveness analysis of breast cancer screening with mammography].
Iinuma T
Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158
[No Abstract] [Full Text] [Related]
6. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography.
Laya MB; Larson EB; Taplin SH; White E
J Natl Cancer Inst; 1996 May; 88(10):643-9. PubMed ID: 8627640
[TBL] [Abstract][Full Text] [Related]
7. The Stockholm Mammographic Screening Trial: Risks and benefits in age group 40-49 years.
Frisell J; Lidbrink E
J Natl Cancer Inst Monogr; 1997; (22):49-51. PubMed ID: 9709275
[TBL] [Abstract][Full Text] [Related]
8. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
[TBL] [Abstract][Full Text] [Related]
9. Two-view versus single-view mammography at subsequent screening in a region of the Dutch breast screening programme.
van Breest Smallenburg V; Duijm LE; den Heeten GJ; Groenewoud JH; Jansen FH; Fracheboud J; Plaisier ML; van Doorne-Nagtegaal HJ; Broeders MJ
Eur J Radiol; 2012 Sep; 81(9):2189-94. PubMed ID: 21906898
[TBL] [Abstract][Full Text] [Related]
10. [Modalities of reading of detection mammographies of the programme in the Bouches-du-Rhône. Results and costs 1990-1995].
Séradour B; Wait S; Jacquemier J; Dubuc M; Piana L
J Radiol; 1997 Jan; 78(1):49-54. PubMed ID: 9091620
[TBL] [Abstract][Full Text] [Related]
11. Mammography and beyond: building better breast cancer screening tests.
Wang L
J Natl Cancer Inst; 2003 Mar; 95(5):344-6. PubMed ID: 12618493
[No Abstract] [Full Text] [Related]
12. Biology and cost-benefit in mammography screening.
Rutqvist LE
Acta Oncol; 1997; 36(7):673-4. PubMed ID: 9490081
[No Abstract] [Full Text] [Related]
13. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling.
Wong IO; Kuntz KM; Cowling BJ; Lam CL; Leung GM
Hong Kong Med J; 2010 Jun; 16 Suppl 3():38-41. PubMed ID: 20601733
[No Abstract] [Full Text] [Related]
15. An overview of the breast cancer screening controversy.
Kopans DB
J Natl Cancer Inst Monogr; 1997; (22):1-3. PubMed ID: 9709266
[TBL] [Abstract][Full Text] [Related]
16. Mass breast cancer screening in The Netherlands: 10 years and counting.
Kuska B
J Natl Cancer Inst; 1998 Dec; 90(23):1764-6. PubMed ID: 9839512
[No Abstract] [Full Text] [Related]
17. Cost-effectiveness of breast cancer screening in Spain.
Plans P; Casademont L; Salleras L
Int J Technol Assess Health Care; 1996; 12(1):146-50. PubMed ID: 8690555
[TBL] [Abstract][Full Text] [Related]
18. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
[TBL] [Abstract][Full Text] [Related]
19. [Cancer of the breast: mass screening by mammography is not justified].
Colin C
Rev Med Liege; 1998 Apr; 53(4):212-3. PubMed ID: 9641016
[TBL] [Abstract][Full Text] [Related]
20. What are the benefits and costs of screening mammograms on Kentucky women aged 40-49?
Spratt JS; Gaines BM; Aaron WS; Cerrito P
J Surg Oncol; 1996 Oct; 63(2):71-6. PubMed ID: 8888797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
